Taro Pharmaceutical Industries Ltd. Net Promoter Score 2020 Benchmarks

Estimated Net Promoter Score is

15

Taro Pharmaceutical Industries is a research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. The company's products are mainly sold in the United States, Canada and Israel. The symbol of the company in NYSE is "TARO".

Taro Pharmaceutical Industries is reported to be on steady growth since 2008. Its revenues have increased from $327 million to an estimated $717 million, and at the same time, its earnings per share have been increasing from $0.76 to an estimated $6.92 during this period.

Quick facts about Taro Pharmaceutical Industries Ltd.

Key people

Kalyanasundaram Subramanian, CEO

Total assets

US$ 1,737.74 million (2015)

Total equity

US$ 1,411.72 million (2015)

Revenue

US$ 862.94 million (2015)

Operating income

US$ 527.63 million (2015)

What is Net Promoter Score?

NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.

It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.

The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.

Learn more about NPS

Is Taro Pharmaceutical Industries Ltd.'s estimated NPS of 15 considered to be good?

Yes, it is.

Net Promoter Score is a number from -100 from 100.

Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.

The industry average for Health Care / Major Pharmaceuticals is 0.

Browse NPS benchmarks

How to understand the NPS benchmarks

The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.

Consider an example: If Taro Pharmaceutical Industries Ltd. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.

On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.

Therefore, comparing the NPS score of Taro Pharmaceutical Industries Ltd. with your own without any further context is not that useful.

What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.

What is Customer.guru? Why is useful?

After successfully using Net Promoter Score for our own e-commerce projects,
 we have decided to let anyone benefit from what we've learned.



We have founded Customer.guru in 2016 to help e-shops, SaaS services and startups better understand their customers, improve their services and increase their revenues.

Customer.guru is an easy-to-setup tool for tracking segmented customer satisfaction using Net Promoter Score.

Learn more

Other companies with Net Promoter Score similar to Taro Pharmaceutical Industries Ltd.

Company Industry Score
AT&T Telecommunications / Cable/TV service 15
HBO Consumer Brands / Entertainment 15
FlexiGroup Financial Services / Banking 15
PNC Banks Financial Services / Banking 15
Lidl Consumer Brands / Grocery 14
Liberty Mutual Insurance / Health and Life Insurance 14
KFC Consumer Brands / Fast Food 14
Sainsburys Consumer Brands / Grocery 16
3 Mobile Telecommunications / Wireless Carrier 16
Morgan Stanley Financial Services / Banking 16

We have estimated the Net Promoter Score of Taro Pharmaceutical Industries Ltd. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.

Do you think this information is incorrect? Report incorrect information. Do you have more accurate data? Submit NPS score.